Gene · 3482
Papers4,462
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,462
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TransTACs: Transforming antibodies into targeted protein degraders. | Acta Pharm Sin B | 2025 | 40177569 | PubTator, text mining | PubMed |
| Molecular glues that inhibit deubiquitylase activity and inflammatory signaling. | Nat Struct Mol Biol | 2025 | 40097626 | PubTator, text mining | PubMed |
| IL-33-Induced TREM2+ Macrophages Promote Pathological New Bone Formation Through CREG1-IGF2R Axis in Ankylosing Spondylitis. | Adv Sci (Weinh) | 2025 | 40091508 | PubTator, text mining | PubMed |
| Trichostatin A-Induced Epigenetic Modifications and Their Influence on the Development of Porcine Cloned Embryos Derived from Bone Marrow-Mesenchymal Stem Cells. | Int J Mol Sci | 2025 | 40076980 | PubTator, text mining | PubMed |
| Deubiquitinase dynamics: methodologies for understanding substrate interactions. | BMB Rep | 2025 | 40058876 | PubTator, text mining | PubMed |
| Mannose-6-phosphate attenuates acute lung injury by competitive release of acid sphingomyelinase from the mannose-6-phosphate receptor in endothelial caveolae. | Eur Respir J | 2025 | 40015747 | PubTator, text mining | PubMed |
| Lysosome-Specific Delivery of β-Glucosidase Enzyme Using Protein-Glycopolypeptide Conjugate via Protein Engineering and Bioconjugation. | Bioconjug Chem | 2025 | 39988831 | PubTator, text mining | PubMed |
| Potential therapeutic targets for colorectal cancer and its subsites: evidence from the proteome-wide Mendelian randomization analyses. | Transl Cancer Res | 2025 | 39974404 | PubTator, text mining | PubMed |
| Engineering IGF2 for Lysosome-targeting chimeras development to target drug-resistant membrane proteins in tumor therapy. | Protein Sci | 2025 | 39969096 | PubTator, text mining | PubMed |
| VARP binds SNX27 to promote endosomal supercomplex formation on membranes. | Sci Adv | 2025 | 39937906 | PubTator, text mining | PubMed |
| Identification of mitophagy-related biomarkers and immune infiltration in polycystic ovarian syndrome by bioinformatic study. | Heliyon | 2025 | 39916834 | PubTator, text mining | PubMed |
| γ-secretase facilitates retromer-mediated retrograde transport. | J Cell Sci | 2025 | 39865938 | PubTator, text mining | PubMed |
| Multiomics approach identifies dysregulated lipidomic and proteomic networks in Parkinson's disease patients mutated in TMEM175. | NPJ Parkinsons Dis | 2025 | 39856101 | PubTator, text mining | PubMed |
| Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics. | Chem Rev | 2025 | 39818743 | PubTator, text mining | PubMed |
| Adrenomedullin 2 attenuates anxiety-like behaviors by increasing IGF-II in amygdala and re-establishing blood-brain barrier. | Transl Psychiatry | 2025 | 39809730 | PubTator, text mining | PubMed |
| CD34+CLDN5+ tumor associated senescent endothelial cells through IGF2-IGF2R signaling increased cholangiocellular phenotype in hepatocellular carcinoma. | J Adv Res | 2025 | 39674501 | PubTator, text mining | PubMed |
| Lysosomal Trafficking and Degradation of Extracellular Proteins via Multivalent Small Molecule Ligand Display on Dextran Scaffolds. | Biomacromolecules | 2025 | 39668457 | PubTator, text mining | PubMed |
| SARS-CoV-2 ORF3a blocks lysosomal cholesterol egress by disrupting VPS39-regulated NPC2 trafficking and BMP metabolism. | bioRxiv | 2025 | 39605369 | PubTator, text mining | PubMed |
| Phosphorylation on serine 72 modulates Rab7A palmitoylation and retromer recruitment. | J Cell Sci | 2025 | 39584231 | PubTator, text mining | PubMed |
| Oncogenic cholesterol rewires lipid metabolism in hepatocellular carcinoma via the CSNK2A1-IGF2R Ser2484 axis. | J Adv Res | 2025 | 39547439 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3482/papers?page=6